As an advisory body, the main functions of TAG-D are to: 

TAG-D provides technical advice relating to WHO’s work on diabetes in several areas. 

• Leadership: TAG-D supports efforts to elevate the priority of diabetes on global and national agendas.  
  • On the prevention side, this includes advocating for stronger action to reduce obesity, especially among young people.
  • On the treatment side, this includes promoting improved access to diabetes medicines and technologies as part of primary health care strengthening efforts, particularly in low- and middle-income countries.
• Global goods: TAG-D is helping to bring all WHO tools for the prevention and management of diabetes together in one package.
• Country support: TAG-D is supporting countries to establish national coverage targets aligned with the WHO global diabetes coverage targets. This work focuses on expanding access to quality diabetes services, including medicines and health technologies, while strengthening accountability and tracking progress in integrating diabetes into primary health care and universal health coverage frameworks. 

Members of TAG-D represent a broad range of disciplines relevant to diabetes. Their expertise includes early diagnosis and treatment, prevention and comorbidities. TAG-D meets online twice a year. 

When selecting TAG-D members, WHO considers the distribution of technical expertise, geographical representation and gender balance across the group. Lived experience of diabetes is also considered in the selection process. 

Members of TAG-D serve for a period of two years and are eligible for reappointment after their term finishes. Sign up for the WHO Global Diabetes Compact newsletter for the latest information about TAG-D recruitment.  

TAG-D members must respect the impartiality and independence required of WHO. Further details about safeguarding WHO from conflicts of interest are included in the TAG-D terms of reference.